Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|March 13, 2014
Exploiting the CD1d-iNKT cell axis for potentiation of DC-based cancer vaccinesRoeland Lameris, Famke L Schneiders, Tanja D de Gruijl, et al.
Frontiers in Immunology|December 7, 2018
Corrigendum: CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and BeyondLisa A King, Roeland Lameris, Tanja D de Gruijl, et al.
Frontiers in Immunology|July 18, 2018
CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and BeyondLisa A King, Roeland Lameris, Tanja D de Gruijl, et al.
Journal for Immunotherapy of Cancer|December 1, 2023
Enhanced CD1d phosphatidylserine presentation using a single-domain antibody promotes immunomodulatory CD1d-TIM-3 interactionsRoeland Lameris, Adam Shahine, Myrthe Veth, et al.
International Journal of Molecular Sciences|January 27, 2021
Preclinical Evaluation of Invariant Natural Killer T Cells Modified with CD38 or BCMA Chimeric Antigen Receptors for Multiple MyelomaRenée Poels, Esther Drent, Roeland Lameris, et al.
Immunology|June 18, 2016
Generation and characterization of CD1d-specific single-domain antibodies with distinct functional featuresRoeland Lameris, Renée C G de Bruin, Paul M P van Bergen En Henegouwen, et al.
ESC Heart Failure|February 19, 2026
Immune Checkpoint Inhibitor Myocarditis: When Profound Troponin Elevation Diverges From Unremarkable ImagingRoel S Driessen, P Stefan Biesbroek, Philippe J van Rosendael, et al.
Critical Reviews in Oncology/Hematology|September 8, 2014
Bispecific antibody platforms for cancer immunotherapyRoeland Lameris, Renée C G de Bruin, Famke L Schneiders, et al.
Pageof 2